Rocket Pharmaceuticals Inc share price logo

Rocket Pharmaceuticals Inc Share Price

NASDAQ: RCKT

Small Cap

$3.03

-0.22

(-6.77%)

as on

Rocket Pharmaceuticals Inc Stock Performance

as on September 18, 2025 at 1:29 am IST

  • Day's High

    $3.03
    $3.25

    7.26%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.19
    $22.01
    downward going graph

    27.72%

    Downside

    626.40%

    Upside

    downward going graph

Rocket Pharmaceuticals Inc share price movements today

Previous Close
$3.25
Open
$3.23
Volume
2.7M
Day's Low - High
$3.03 - $3.25
52 Week Low - High
$2.19 - $22.01

Rocket Pharmaceuticals Inc Historical Returns

1 Month Return
+ 5.57 %
3 Month Return
+ 18.38 %
1 Year Return
-85.23 %
3 Year Return
-76.98 %
5 Year Return
-87.01 %

Rocket Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Rocket Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$350.7M

EPS (TTM)

-2.1142

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-253.9M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

0.00%

Rocket Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Rocket Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$350.7M-87.01%NA0.00%
BUY$60.5B252.04%-505.15-12.96%
NA$39.0BNANA-3.89%
BUY$100.3B44.17%27.8531.86%
BUY$59.6B1.78%14.131.37%

Stock Returns calculator for Rocket Pharmaceuticals Inc Stock including INR - Dollar returns

The Rocket Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Rocket Pharmaceuticals Inc investment value today

Current value as on today

₹18,497

Returns

₹81,503

(-81.5%)

Returns from Rocket Pharmaceuticals Inc Stock

₹86,101 (-86.1%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Rocket Pharmaceuticals Inc Stock

Based on 21 analysts

BUY

90.48%

Buy

9.52%

Hold

0.00%

Sell

Based on 21 analysts, 90.48% of analysts recommend a 'BUY' rating for Rocket Pharmaceuticals Inc. Average target price of $7.86

Rocket Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Rocket Pharmaceuticals Inc.

What analysts predicted

61.45%UPSIDE

Target Price

$7.86

Current Price

$3.03

Analyzed by

21 Analysts

Target

$7.86

Rocket Pharmaceuticals Inc target price $7.86, a slight upside of 61.45% compared to current price of $3.03. According to 21 analysts rating.

Rocket Pharmaceuticals Inc Stock's Interest Amongst Investors

Investment in Rocket Pharmaceuticals Inc Shares on INDmoney has grown by 206.66% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:206.66% versus previous 30 day period

Search interest for Rocket Pharmaceuticals Inc Stock has increased by 37% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:37% versus previous 30 day period

Rocket Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
10
-
-
-
9
-
-
Gross Profit
-1
-1
-1
5
-2
-2
-2
4
-2
-2
Operating Income
-62
-68
-65
-63
-67
-73
-69
-62
-64
-71
EBITDA
-56
-63
-59
-56
-59
-66
-63
-57
-57
-65
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
1
1
1
1
2
2
2
2
2
2
Income Before Tax
-58
-65
-61
-59
-62
-69
-66
-60
-61
-68
Income Tax Expense
-3
3
-1
1
0
-
-66
-
-
-
Net Income
-54
-65
-61
-59
-62
-69
-66
-60
-61
-68
Net Profit Margin
0.00%
0.00%
0.00%
-578.55%
0.00%
0.00%
0.00%
-656.73%
0.00%
0.00%

Rocket Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
-1
-5
-6
-7
-9
Operating Income
-20
-41
-26
-71
-76
-134
-167
-224
-259
-273
EBITDA
-20
-41
-26
-71
-71
-131
-161
-213
-236
-247
Interest Expense
1
1
3
5
4
7
5
1
1
1
Depreciation
-
-
0
0
0
1
5
6
6
9
Income Before Tax
-67
-42
-29
-74
-77
-139
-169
-221
-245
-258
Income Tax Expense
1
0
0
2
5
6
0
-2
-245
0
Net Income
-67
-42
-29
-74
-83
-146
-169
-219
-245
-258
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Rocket Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-65
-61
-59
-62
-69
-66
-60
-61
-68
Operating Cash Flow
-50
-57
-29
-56
-53
-52
-46
-55
-48
Investing Cash Flow
31
48
-140
35
55
78
-37
-58
31
Financing Cash Flow
0
189
0
1
1
0
182
0
0
Change in Cash
-19
180
-169
-20
3
26
98
-113
-16

Rocket Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-42
-29
-74
-77
-139
-169
-221
-245
-258
Operating Cash Flow
-37
-26
-53
-64
-74
-121
-178
-194
-209
Investing Cash Flow
-66
75
-5
-39
-96
18
-69
-98
131
Financing Cash Flow
0
0
153
177
282
37
155
208
185
Change in Cash
-50
48
94
74
111
-64
-92
-84
107

Global Institutional Holdings in Rocket Pharmaceuticals Inc

Funds
Holdings
RTW INVESTMENTS, LLC
16.4%
Wellington Management Company LLP
11.7%
BlackRock Inc
6.74%
Vanguard Group Inc
6.13%
Maverick Capital Ltd
4.82%

Rocket Pharmaceuticals Inc News & Key Events

  • img

    Today's Timeline - 20 August

    Wed, 05:05 PM

    -

    FDA lifts clinical hold on Rocket Pharmaceuticals' RP-A501 gene therapy trial for Danon disease, allowing it to resume with adjusted dosing.

Insights on Rocket Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 193.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.1% return, outperforming this stock by 153.2%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, RCKT stock has moved down by -63.2%

About Rocket Pharmaceuticals Inc

rocket pharmaceuticals, ltd is a biotechnology company focused on seeking cures through molecular and gene therapy. we are developing first-in-class treatments for patients with rare and often devastating orphan diseases using a lentiviral-based gene therapy approach. we have developed rewarding partnerships with a number of leading international research institutions as well as with centers of manufacturing and cell processing expertise, while building an internal team to drive the research, development, clinical and regulatory programs. ultimately we aim to launch and globally commercialize innovative gene therapies in disease areas with high unmet need. for more information, please visit www.rocketpharma.com.
OrganisationRocket Pharmaceuticals Inc
Headquarters9 Cedarbrook Drive, Cranbury, NJ, United States, 08512
IndustryHealth Technology
CEODr. Gaurav D. Shah M.D.
E-voting on sharesClick here to vote

Key Management of Rocket Pharmaceuticals Inc

Name

Title

Dr. Gaurav D. Shah M.D.

CEO & Director

Mr. Martin Louis Wilson J.D.

Gen. Counsel, Secretary, Interim Prin. Financial Officer, Chief Comp. Officer & Chief Corp. Officer

Ms. Meg Dodge

Vice President of Investor Relations & Corporate Communications

Dr. Jonathan Schwartz M.D.

Chief Medical & Gene Therapy Officer

Dr. Kinnari Patel M.B.A., Pharm.D.

Executive Officer

Mr. Christopher Stevens

Chief Operating Officer

Ms. Isabel Carmona J.D.

Chief People Officer

Dr. Gayatri R. Rao J.D., M.D.

Senior VP of Clinical Safety & Chief Regulatory Officer

Mr. Raj Prabhakar M.B.A.

Chief Business Officer

Ms. Sarbani Chaudhuri M.B.A.

Chief Commercial & Medical Affairs Officer

FAQs

What is Rocket Pharmaceuticals Inc share price today?

Rocket Pharmaceuticals Inc share price today is $3.03 as on at the close of the market. Rocket Pharmaceuticals Inc share today touched a day high of $3.25 and a low of $3.03.

What is the 52 week high and 52 week low for Rocket Pharmaceuticals Inc share?

Rocket Pharmaceuticals Inc share touched a 52 week high of $22.01 on and a 52 week low of $2.19 on . Rocket Pharmaceuticals Inc stock price today i.e. is closed at $3.03,which is 86.23% down from its 52 week high and 38.36% up from its 52 week low.

What is Rocket Pharmaceuticals Inc's market capitalisation today?

Rocket Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in Rocket Pharmaceuticals Inc Stock (RCKT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Rocket Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Rocket Pharmaceuticals Inc Shares that will get you 0.4950 shares as per Rocket Pharmaceuticals Inc share price of $3.03 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Rocket Pharmaceuticals Inc Stock (RCKT) from India?

Indian investors can start investing in Rocket Pharmaceuticals Inc (RCKT) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Rocket Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Rocket Pharmaceuticals Inc share’s latest price of $3.03 as on September 18, 2025 at 1:29 am IST, you will get 3.3003 shares of Rocket Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Rocket Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Rocket Pharmaceuticals Inc stock has given -87.01% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?